Empasug ST 100/10
MRP: 2,099
Packaging: 10X10
Pack Type: tablet
Composition:
Empagliflozin 10 mg + Sitagliptin 100 mg
Indication:
Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. Combines SGLT2 inhibitor (Empagliflozin) and DPP-4 inhibitor (Sitagliptin) for dual glucose-lowering action. Not for type 1 diabetes or diabetic ketoacidosis.
Description:
Empagliflozin 10mg + Sitagliptin 100mg is a fixed-dose combination tablet for the treatment of type 2 diabetes mellitus. This combination combines two effective antidiabetic agents with complementary actions:
Empagliflozin (10mg): An SGLT2 inhibitor that lowers blood glucose by increasing the amount of glucose excreted in the urine.
Sitagliptin (100mg): A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that increases insulin secretion and decreases glucagon release in a glucose-dependent manner.
This dual-action combination helps improve blood sugar control, supports weight management, and reduces the risk of cardiovascular complications associated with diabetes. It is intended for patients who require better glycemic control than monotherapy provides.
Tags:
- Effective dual action for blood sugar control
- Supports weight management
- Reduces risk of cardiovascular complications
- Convenient once-daily dosing
- Minimizes hypoglycemia risk
Usage Information
Dosage
Take one tablet once daily, with or without food. Follow your healthcare provider’s instructions. Maintain hydration during treatment.
Side Effects
Common side effects: Urinary tract infections Nasopharyngitis Increased urination Headache Gastrointestinal discomfort Serious but rare: Diabetic ketoacidosis Severe allergic reactions Pancreatitis
Contraindications
Type 1 diabetes or diabetic ketoacidosis Severe renal impairment (eGFR < 30 mL/min/1.73m²) Hypersensitivity to Empagliflozin, Sitagliptin, or excipients History of pancreatitis (use with caution) Pregnant or breastfeeding women (consult doctor)